Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy

被引：0
|
作者：
Kotoha Tatekawa
Hiromitsu Iwata
Takatsune Kawaguchi
Satoshi Ishikura
Fumiya Baba
Shinya Otsuka
Akifumi Miyakawa
Maho Iwana
Yuta Shibamoto
机构：
[1] Nagoya City University Hospital,Department of Radiology
[2] Nagoya Proton Therapy Center,Department of Radiation Oncology
[3] Nagoya West Medical Center,Department of Radiation Oncology
[4] Juntendo University,Department of Radiation Oncology
[5] Nagoya West Medical Center,undefined
来源：
Radiation Oncology | / 9卷
关键词：
Squamous Cell Carcinoma; Tumor Volume; Stereotactic Body Radiotherapy; Gross Tumor Volume; Japan Clinical Oncology Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] Nodal recurrences after stereotactic body radiotherapy for early stage non-small-cell lung cancer
    Tibdewal, Anil
    Pathak, Rima S.
    Agarwal, Jai Prakash
    Hoskote, Sumedh S.
    Mummudi, Naveen
    Iyer, Veena
    Nair, Akshay G.
    CURRENT PROBLEMS IN CANCER, 2021, 45 (02)
  • [22] QUANTIFICATION OF TUMOR VOLUME CHANGES DURING RADIOTHERAPY FOR NON-SMALL-CELL LUNG CANCER
    Fox, Jana
    Ford, Eric
    Redmond, Kristin
    Zhou, Jessica
    Wong, John
    Song, Danny Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02): : 341 - 348
  • [23] Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non-Small-Cell Lung Cancer
    Grills, Inga S.
    Mangona, Victor S.
    Welsh, Robert
    Chmielewski, Gary
    McInerney, Erika
    Martin, Shannon
    Wloch, Jennifer
    Ye, Hong
    Kestin, Larry L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 928 - 935
  • [24] Stereotactic single-dose radiotherapy of Stage I non-small-cell lung cancer (NSCLC)
    Hof, H
    Herfarth, KK
    Münter, M
    Hoess, A
    Motsch, J
    Wannenmacher, M
    Debus, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02): : 335 - 341
  • [25] Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?
    Haasbeek, Cornelis J. A.
    Lagerwaard, Frank J.
    Cuijpers, Johan P.
    Slotman, Ben J.
    Senan, Suresh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05): : 1370 - 1374
  • [26] Stereotactic radiotherapy for stage I non-small-cell lung cancer - the triumph of technology over biology?
    Ball, David
    Withers, H. Rodney
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (11): : 614 - 615
  • [27] Stereotactic radiotherapy for stage I non-small-cell lung cancer—the triumph of technology over biology?
    David Ball
    H Rodney Withers
    Nature Clinical Practice Oncology, 2007, 4 : 614 - 615
  • [28] Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC)
    Janssen, Stefan
    Kaesmann, Lukas
    Rudat, Volker
    Rades, Dirk
    LUNG, 2016, 194 (02) : 291 - 294
  • [29] Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?
    Mirimanoff, Rene-Olivier
    CHINESE CLINICAL ONCOLOGY, 2015, 4 (04)
  • [30] Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC)
    Stefan Janssen
    Lukas Kaesmann
    Volker Rudat
    Dirk Rades
    Lung, 2016, 194 : 291 - 294
12345